Teva's Seffalair And BroPair Spiromax Receive Approval In EU
Teva Pharmaceuticals Europe - Home | Facebook
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Strategy for inhaled corticosteroid use leads to better asthma outcomes, according to national study of Black and Latinx patients | UIC Today
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva Pharmaceutical Gets a Taste of Its Own Medicine As the FDA Approves a Generic of Its Asthma Drug | The Motley Fool
Teva Pharmaceuticals receives European approval for Spiromax inhalers - Drug Delivery Business
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva Pharmaceuticals on Twitter: "Are you attending #AAAAI21? Be sure to visit our virtual booth to learn more about Teva's work to improve care for #asthma and #COPD patients. https://t.co/2vgkja3Zli https://t.co/ybwPHkAdOX" /
Teva Launches 2 New Digital Maintenance Inhalers
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma
EU nod for Teva's asthma biologic - PharmaTimes
Teva's Asthma Segment: What Could Boost Its Revenues in 2016?
Teva Pharmaceuticals Prepares for Upcoming Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceuticals releases its prescription ProAir Digihaler in the US | MobiHealthNews
